TITLE

Whole-body CT health screening

AUTHOR(S)
Dixon A K
PUB. DATE
May 2004
SOURCE
British Journal of Radiology;May2004, Vol. 77 Issue 917, p370
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
14593980

 

Related Articles

  • Who's for a body scan? Greenhalgh, Trisha // Accountancy;Aug2005, Vol. 136 Issue 1344, p108 

    Discusses the dangers of whole-body computed tomography (CT) screening. Assumptions by private companies offering a scan of any part of the body; Disadvantages of CT scans; Implications of periodical CT scans for human health.

  • symposium. Cihak, Robert J.; Glueck, Michael A.; Stanley, Robert J. // Insight on the News;7/23/2001, Vol. 17 Issue 27, p40 

    Presents contrasting opinions on the safety of whole-body computed tomography (CT) scan. Benefits of low-dose x-ray; Impetus behind the push for whole-body CT screening; Worry about the whole-body CT screen.

  • getting a glimpse of what's up inside. Gorney, Cynthia // Health (Time Inc. Health);Jun2001, Vol. 15 Issue 5, p74 

    Provides information on whole-body computerized tomography (CT) scanning. Some myths about CT scan procedure; Facts to be discovered during a screening.

  • Computed tomographic screening for lung cancer: home run or foul ball? Swensen, Stephen J.; Jett, James R.; Midthun, David E.; Hartman, Thomas E. // Mayo Clinic Proceedings;Sep2003, Vol. 78 Issue 9, p1187 

    Discusses the sensitivity of computed tomography (CT) in screening lung cancer at earlier stages. Whole-body CT screening; Radiation exposure issues; Comparison of performance between CT and chest radiography.

  • Whole-body screening CT--Good medicine or good business? Borgstede, James P.; Fishman, Elliot K. // Patient Care;Jul2003, Vol. 37 Issue 7, p28 

    Discusses the effectiveness and ineffectiveness of whole-body screening computed tomographic (WBS-CT). Difference between targeted CT and WBS-CT; Views of the U.S. Food and Drug Administration on WBS-CT; Advice for primary care physicians in recommending WBS-CT to patients.

  • What you need to know about whole-body CT scans.  // Patient Care for the Nurse Practitioner;Jul2003, Vol. 6 Issue 7, p8 

    The article presents information on whole-body screening computed tomography (WBS-CT). Several commercial operations now offer WBS-CT scans to detect diseases like cancer at a very early stage when they might be more curable. There is little or no evidence for using CT screening in someone with...

  • Whole-body screening CT--Good medicine or good business? Borgstede, James P.; Fishman, Elliot K. // Patient Care for the Nurse Practitioner;Jul2003, Vol. 6 Issue 7, p7 

    The article presents information on whole-body screening computed tomographic (WBS-CT). The cost of a WBS-CT scan typically ranges from $800 to $1500. Medicare and most insurance companies do not reimburse for this procedure. The American College of Radiology has reiterated its recommendation...

  • A Fit Market? Bassett, Michael // Imaging Economics;May/Jun2014, Vol. 27 Issue 3, p28 

    The article offers the insight of several health experts on the potential of whole-body computed tomography (CT) scans in the market and their benefits and disadvantages. According to Jonathan Berlin, whole-body scanning is not considered to be a viable business model because it cannot provide...

  • Three-dimensional echocardiography and Sm-EDTMP SPECT/CT in extensive cardiac metastases from osteosarcoma. Tiemann, Klaus; Stymann, Jörg; Landeta, Federico; Wiebe, Stefanie; Schäfers, Michael; Schober, Otmar; Weckesser, Matthias; Rahbar, Kambiz // European Journal of Nuclear Medicine & Molecular Imaging;Dec2010, Vol. 37 Issue 12, p2406 

    The article discusses the application of three-dimensional (3D) echocardiography, Sm-ethylenediaminetetramethylenephosphonate (EDTMP) and single-photon emission computed tomography (SPECT)/computed tomography (CT) in a 32-year-old woman with a history of osteosarcoma. It states that...

  • Is whole-body FDG-PET valuable for health screening? Ide, Michiru; Suzuki, Yutaka // European Journal of Nuclear Medicine & Molecular Imaging;Mar2005, Vol. 32 Issue 3, p339 

    This article discusses whether whole-body FDG-PET ([sub18]F-fluoro-2-deoxy-D-glucose positron emission tomography) is valuable for health screening. Cancer is still the leading cause of death in developing countries. The success of cancer treatment is highly dependent on early detection. There...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics